Skip to main content
Figure 3 | Reproductive Biology and Endocrinology

Figure 3

From: Outpatient management of severe early OHSS by administration of GnRH antagonist in the luteal phase: an observational cohort study

Figure 3

Distribution of ascites levels during the monitoring period. *At the end of the monitoring period, on day 11, “moderate-marked ascites” included 14 women (35%), of which 11 (27.5%) had moderate ascites, and only 3 (7.5%) had marked ascites. No women (0%) had “massive-tense” ascites, while the majority of women (65%) had no or low levels of ascites on day 11 of monitoring (chi-square p < 0.01).

Back to article page